5 Must-Read Analyst Questions From Henry Schein’s Q1 Earnings Call
Henry Schein Inc HSIC
$72.26
▼ -0.48%
($-0.35)
Index member:
S&P 500
Open
$72.65
Prev Close
$72.61
Day Range
$71.50 – $72.87
52W Range
$61.95 – $89.29
Market Cap
$7.90B
P/E (TTM)
20.93
Beta
0.82
EPS (TTM)
$3.31
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1995-11-03 |
| Shares Out. | 114,750,000 |
| Website | henryschein.com/ ↗ |
| Phone | 13026365400 |
Henry Schein Inc is a publicly traded company under the ticker symbol HSIC on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
24 analysts (2026-05-01)
📰 Latest News for HSIC
Henry Schein One Releases 2026 Catalyst Index, Revealing Clinical Performance as the Primary Driver of Growth
Henry Schein, Inc. (HSIC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Transcript : Henry Schein, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 02
Henry Schein : 2026 Proxy Supplement May 12, 2026 of 2025
Earnings Beat: Henry Schein, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
UBS Maintains Neutral on Henry Schein, Lowers Price Target to $85
Mizuho Maintains Neutral on Henry Schein, Lowers Price Target to $82
